Publication:
The treatment outcomes of oligometastatic colorectal cancer patients treated with stereotactic body radiation therapy: a multi-institutional analysis TROD 02-008

Placeholder

Departments

Organizational Unit

School / College / Institute

Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU Authors

Co-Authors

Guler, O. C.
Hurmuz, P.
Atalar, B.
Guney, Y. Yukselen
Saglam, E. K.
Akyurek, S.
Gural, Z.
Tugrul, F.
Korcum, A. F.
Sen, C. A.

Publication Date

Language

Embargo Status

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Purpose/Objective(s):Stereotacticbodyradiotherapy(SBRT) is increasinglybeingusedtotreatoligometastaticcancers,buthigh-levelevidenceto supportpolicydecisions is lacking inpatientswithcolorectal carcinoma (CRC).Thepurposeof thisstudywastodeterminetheprognosticfactors forsurvival inoligometastaticcolorectalcancerpatientstreatedwithSBRT inamulticentricsetting. Materials/Methods:Theclinicaldataof437oligometastaticCRCpatients whoreceivedmetastasisdirectedtreatment(MDT)viaSBRTat18institutionsbetweenFebruary2007andFebruary2021werereviewedretrospectively.Patientseitherhaddenovooligometastasis (≤5metastases)at the timeofdiagnosisorhadoligometastaticrecurrencesduringfollow-up.All patientswere treatedwith the goal of curing theirmetastasis, and839 lesionswereirradiated. Results:Theaverageagewas61years(range;27-92years).Themajorityof patients(58.8%)hadcoloncarcinomawithasingleorganmetastasis(88.8 %).Theaveragenumberofmetastatic lesionswas2(range, 1-5).There were103patientswithlivermetastasis,222patientswithlungmetastasis, 58patientswithlymphnodemetastasis,60patientswithbonemetastasis, 32patientswithbrainmetastasis,and6patientswithotherorganmetastasis.BeforeRT,themedianCEAandCa-19-9levelswere5.16ng/mL(range: 0-8181.1ng/mL)and19.4(range:0.60-3693), respectively.AfterRT, the medianCEAandCa-19-9were5.00ng/mL(range,0.4-5693vng/mL)and 18(range,0-6577),respectively.Theaverageperiodoffollow-upwas15.2 months(range,0.3-91.5months).TheratesofOSandPFSaftertwoyears were 76.3% and 28.1%, respectively. Age (p<0.001), pre-RTCEA (p=0.006),pre-RTCa19-9(p=0.02),post-RTCEA(p=0.01), andpost-RT Ca19-9(p=0.02)wereallsignificantprognosticfactorsforOSinunivariate analysis.Age (HR=1.03, 95%CI, 1.01-1.04, p=0.004) andpre-RTCEA (HR=1.01,95%CI,1.00-1.02,p=0.04)wereindependentpredictorsofOS inmultivariateanalysis,whilepost-RTCEA(HR=1.93,95%CI,1.28-2.90, p=0.002)wasanindependentpredictorofPFS. Conclusion: SBRTtooligometastatic lesionswas foundtobeasafeand effective treatmentmodality forpatientswithcolorectal cancer. Survival waspredictedbyage, baselineCEA, and theCa19-9response toMDT. Additionalprospectivestudieswithlargercohortsarenecessarytovalidate ourfindings.

Source

Publisher

Elsevier

Subject

Oncology, Radiology, Nuclear medicine, Medical imaging

Citation

Has Part

Source

International Journal of Radiation Oncology Biology Physics

Book Series Title

Edition

DOI

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads